Vietnam hospital launches eye study to spot diabetes damage early
NCT ID NCT07468058
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will review medical records of 300 diabetes patients at a hospital in Da Nang, Vietnam, to see how many have diabetic retinopathy—a condition that can harm vision. Researchers will also look for factors that make the disease more likely. No new treatment is being tested; the goal is simply to gather information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This hospital-based retrospective cohort study included adult patients with diabetes mellitus who attended the Endocrinology-Diabetes Center and underwent ophthalmologic evaluation at the Eye Clinic of Family General Hospital, Da Nang, Vietnam, between January 2025 and September 2025.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed diabetes mellitus (type 1 or type 2) according to ADA criteria * Underwent ophthalmic examination including dilated fundus examination and OCT * Available electronic medical records with key clinical and laboratory data Exclusion Criteria: * Gestational diabetes mellitus * Media opacity precluding fundus examination (advanced cataract, corneal opacity, dense vitreous hemorrhage) * Other retinal diseases (e.g., hypertensive retinopathy, retinal vein occlusion) * History of ocular trauma or intraocular surgery within 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic retinopathy (DR) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Endocrinology and Diabetes
RECRUITINGDa Nang, 50000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can tight blood sugar control protect the eyes? a study uses advanced imaging to find out
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?
- Could a common supplement protect eyes in diabetes?
- Eye scan showdown: faricimab vs ranibizumab in diabetic retinopathy